Anúncio
Anúncio

EHC

EHC logo

Encompass Health Corporation Common Stock

104.97
USD
Patrocinado
-1.40
-1.31%
08 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

104.97

0.00
0.00%

Relatórios de Lucros EHC

Rácio de surpresa positiva

EHC separação 33 de 40 últimas estimativas.

83%

Próximo Relatório

Data do Próximo Relatório
04 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.56B
/
$1.31
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+5.38%
/
+6.50%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+10.82%
/
+11.97%

Encompass Health Corporation Common Stock earnings per share and revenue

On 29 de out. de 2025, EHC reported earnings of 1.23 USD per share (EPS) for Q3 25, beating the estimate of 1.20 USD, resulting in a 1.94% surprise. Revenue reached 1.48 bilhão, compared to an expected 1.50 bilhão, with a -1.18% difference. The market reacted with a -7.02% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analistas forecast an EPS of 1.31 USD, with revenue projected to reach 1.56 bilhão USD, implying an aumentar of 6.50% EPS, and aumentar of 5.38% in Revenue from the last quarter.
FAQ
For Q3 2025, Encompass Health Corporation Common Stock reported EPS of $1.23, beating estimates by 1.94%, and revenue of $1.48B, -1.18% below expectations.
The stock price moved down -7.02%, changed from $125.63 before the earnings release to $116.81 the day after.
The next earning report is scheduled for 04 de fev. de 2026.
Based on 13 analistas, Encompass Health Corporation Common Stock is expected to report EPS of $1.31 and revenue of $1.56B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio